Medline files for IPO with SEC, plans NASDAQ listing

Medline Inc. filed a registration statement on Form S-1 with the Securities and Exchange Commission for a proposed initial public offering of its common stock, the company announced Monday.

The Northfield, Illinois-based company plans to list its shares on the Nasdaq Global Select Market under the ticker symbol "MDLN" if the offering is completed.

The registration statement has not yet become effective, and the number of shares to be offered, price range, and other terms have not been determined. The offering remains subject to market conditions and SEC approval, with no assurance regarding timing or completion.

Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities, and J.P. Morgan are serving as lead bookrunning managers for the proposed offering.

Medline operates as a healthcare products manufacturer and distributor. The company's IPO plans represent a potential return to public markets after being taken private in a $34 billion deal in 2021.

The offering will be conducted solely through a prospectus once available. The registration statement filing does not permit the sale of securities or acceptance of purchase offers until it becomes effective.

You May Also Be Interested In